Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
post-traumatic stress disorder/головная боль
Ссылка сохраняется в буфер обмена
Страница 1 от 26 полученные результаты
Treatment of migraine, post-traumatic headache, tension-type headaches, atypical facial pain, cervical pain and muscle spasm
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
The present invention relates to a new method for the treatment of migraine, tension-type headaches, atypical facial pain, post-traumatic headache, cervical pain and muscle spasm.
In accordance with the invention, the method of treatment for these headaches, atypical
Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
This invention relates to a method for treatment of migraine, tension-type headache, post-traumatic headache, facial pain and cervical-muscle spasm. More particularly the invention relates to a method of treatment which is non-invasive, non-toxic and non-sedating. The method of the invention
Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
This invention relates to a method for treatment of migraine, tension-type headache, post-traumatic headache, facial pain and cervical muscle spasm. More particularly the invention relates to a method of treatment which is non-invasive, non-toxic and non-sedating. The method of the invention
Extramuscular treatment of traumatic-induced migraine headache
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Trauma has been documented to increase frequency of migraine headache and is a risk factor for conversion from episodic to chronic migraine.
Anxiety and depression are more often associated with chronic migraine than episodic migraine, while trauma may be implicated in initiating or worsening
Treatment of traumatic-induced migraine headache
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Trauma has been documented to increase frequency of migraine headache and is a risk factor for conversion from episodic to chronic migraine.
Anxiety and depression are more often associated with chronic migraine than episodic migraine, while trauma may be implicated in initiating or worsening
Method of treatment
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
This invention relates to new uses of certain indole derivatives in the treatment or prophylaxis of medical disorders.
International Patent Application WO 92/06973 discloses a series of indole derivatives which are potent serotonin (5-HT) agonists. These compounds are useful for treating disorders
Pyrimido [4,5,b]indolizine derivatives and aza analogues thereof; CRF1 specific ligands
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to pyrido[2,3-b]indolizine derivatives and aza analogues thereof that selectively bind to corticotropin-releasing factor (CRF) receptors. It also relates to pharmaceutical compositions comprising such compounds. It further
Pyrido[2,3-b]indolizine derivatives and aza analogues thereof: CRF1 specific ligands
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to pyrido[2,3-b]indolizine derivatives and aza analogues thereof that selectively bind to corticotropin-releasing factor (CRF) receptors. It also relates to pharmaceutical compositions comprising such compounds. It further
Substituted azole derivatives as inhibitors of corticotropin releasing factor
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to thiazoles, oxazoles, imidazoles and pharmaceutical compositions comprising said compounds antagonizing the corticotropin releasing factor receptor ("CRF receptor") and useful for the treatment of depression, anxiety, affective disorders,
Pyridinyl derivatives for the treatment of depression
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to antagonists and pharmaceutical compositions comprising said antagonists of the corticotropin releasing factor receptor ("CRF receptor") useful for the treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic
Imidazolyl derivatives as corticotropin releasing factor inhibitors
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to antagonists and pharmaceutical compositions comprising said antagonists of the corticotropin releasing factor receptor ("CRF receptor") useful for the treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic
Imidazolyl derivatives as corticotropin releasing factor inhibitors
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to antagonists and pharmaceutical compositions comprising said antagonists of the corticotropin releasing factor receptor ("CRF receptor") useful for the treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic
Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to isoquinolinamine and phthalazinamine derivatives which selectively bind to corticotropin-releasing factor (CRF) receptors. This invention also relates to pharmaceutical compositions comprising such compounds. It fuirther
Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to isoquinolinamine and phthalazinamine derivatives which selectively bind to corticotropin-releasing factor (CRF) receptors. This invention also relates to pharmaceutical compositions comprising such compounds. It further
Method and device for the treatment of anxiety disorders
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention pertains to a method and a device for the treatment of anxiety disorders including panic attacks.
2. Description of Related Prior Art
Anxiety disorders are common psychiatric illnesses associated with considerable morbidity
Самая полная база данных о лекарственных травах, подтвержденная наукой
- Работает на 55 языках
- Травяные лекарства, подтвержденные наукой
- Распознавание трав по изображению
- Интерактивная карта GPS - отметьте травы на месте (скоро)
- Прочтите научные публикации, связанные с вашим поиском
- Ищите лекарственные травы по их действию
- Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов
Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.
